Related references
Note: Only part of the references are listed.In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells
N. Arai et al.
ORAL DISEASES (2013)
Influence of Bone Affinity on the Skeletal Distribution of Fluorescently Labeled Bisphosphonates In Vivo
Anke J. Roelofs et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
The Bone Scan
Arnold I. Brenner et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Biochemical and molecular mechanisms of action of bisphosphonates
Michael J. Rogers et al.
BONE (2011)
Bisphosphonates Induce Senescence in Normal Human Oral Keratinocytes
R. H. Kim et al.
JOURNAL OF DENTAL RESEARCH (2011)
SYNTHESIS AND CHARACTERIZATION OF NOVEL FLUORESCENT NITROGEN-CONTAINING BISPHOSPHONATE IMAGING PROBES FOR BONE ACTIVE DRUGS
Shuting Sun et al.
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS (2011)
Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents
G. Andrei et al.
ANTIVIRAL RESEARCH (2010)
Adverse Effects of Bisphosphonates
Bo Abrahamsen
CALCIFIED TISSUE INTERNATIONAL (2010)
Fluorescent Risedronate Analogues Reveal Bisphosphonate Uptake by Bone Marrow Monocytes and Localization Around Osteocytes In Vivo
Anke J. Roelofs et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Skin and oral mucosa equivalents: construction and performance
J. Liu et al.
ORTHODONTICS & CRANIOFACIAL RESEARCH (2010)
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis
Mark A. Scheper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
The skin: an indispensable barrier
Ehrhardt Proksch et al.
EXPERIMENTAL DERMATOLOGY (2008)
Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
B. Ory et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Inhibition of oral mucosal cell wound healing by bisphosphonates
Regina Landesberg et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2008)
Cancer treatment-induced bone loss: Pathophysiology and clinical perspectives
Adam M. Brufsky
ONCOLOGIST (2008)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Organotypic human oral tissue models for toxicological studies
Mitchell Klausner et al.
TOXICOLOGY IN VITRO (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment
Liran Levin et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2007)
Bisphosphonates and osteonecrosis of the jaw:: cause and effect or a post hoc fallacy?
T. Van den Wyngaert et al.
ANNALS OF ONCOLOGY (2006)
Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells
M Goffinet et al.
BMC CANCER (2006)
Recent advances in understanding the mechanism of action of bisphosphonates
Fraser P. Coxon et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer
Matthew L. Goldman et al.
ONCOLOGY (2006)
Stratum corneum defensive functions: An integrated view
PM Elias
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
REVIEW: What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates
DY Graham
DIGESTIVE DISEASES AND SCIENCES (2002)
Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway:: A model of bisphosphonate-induced gastrointestinal toxicity
S Suri et al.
BONE (2001)
Bisphosphonates induce apoptosis in human breast cancer cell lines
SG Senaratne et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
